New Study: Night-time heat significantly increases the risk of stroke
mehr
Ergebnis der Suchanfrage nach Allergie
Newsrooms
Inhalte
- Kategorie:
- Sprache:
- Medien:
- Zeitraum:
- Zeitraum:Gesamt
41 Treffer
Advanced Brain Science Without Coding Expertise
mehrAsthma in Children: Researchers Envision Novel Drug to Reduce the Risk of the Disease
Asthma in Children: Researchers Envision Novel Drug to Reduce the Risk of the Disease Scientists have reached a milestone in the research of childhood asthma. For the first time, they have clarified how a certain genetic defect in children initially leads to frequent infections and later to asthma. The study, published in the American Journal of Respiratory and ...
mehrScientists Reveal Adipocyte's Metabolic Role and Identify Treatment Targets
mehrRising Focus on 'Inceptor' as a Type 2 Diabetes Therapeutic Target
mehrTherapeutic Vaccine for Chronic Hepatitis B Enters Clinical Trial
mehrWhat Our Genetic Information Tells Us About Type 2 Diabetes Risk and Complications
mehrCells of the Future: A Key To Reprogramming Cell Identities
mehrNew Source of Stem Cells in Injury-Affected Brains of Patients
mehrTakeda Pharma Vertrieb GmbH & Co. KG
The European Commission Approves Label Update for TAKHZYRO® (lanadelumab), Expanding Its Use to a Broader Group of Paediatric Patients with Recurrent Attacks of Hereditary Angioedema (HAE)
Zurich (ots/PRNewswire) - - TAKHZYRO® is the First Routine Prevention Treatment of HAE Approved in the EU for Patients Under the Age of Six. - The therapeutical indication for TAKHZYRO® has been extended to patients aged 2 years and older.1 - Offers a New Preventative Treatment Option for young HAE patients with ...
mehrEuropean Academy of Allergy and Clinical Immunology
EAACI International Severe Asthma Forum (ISAF) Hybrid 2023: Advancing Severe Asthma Care
Zurich (ots/PRNewswire) - The Organising Committee of the EAACI International Severe Asthma Forum (ISAF) is pleased to announce the upcoming ISAF Hybrid 2023 event, scheduled to take place in the historic city of Rome from October 05 to October 07, 2023. This event will unite global experts and emerging professionals to address the challenges of severe asthma and ...
mehrTakeda Pharma Vertrieb GmbH & Co. KG
Takeda Receives Positive CHMP Opinion Recommending Approval of Lanadelumab for Routine Prevention of Recurrent Attacks of Hereditary Angioedema (HAE) in Patients Aged 2 years and Older
Zurich (ots/PRNewswire) - - If Approved, Lanadelumab Will be the First Long-Term Prophylactic Treatment of HAE Available in the EU for Patients Under the Age of Six. - Positive Opinion Based on Pivotal Study SHP643-301, Evaluating the Safety Profile and Pharmacokinetics (PK) of Lanadelumab, in Combination with ...
mehrA New Ally in Fighting Brain Diseases: Our Very Own Skull
mehrLife Science Factory to Open a New Location in Munich in 2024
mehrGrünenthal and Kyowa Kirin International Announce Successful Completion of Deal to Enter Joint Venture Collaboration
Aachen, Germany and Tokyo, Japan (ots) - - The Joint Venture Collaboration includes a portfolio of 13 brands across six therapeutic areas, with the majority of revenue resulting from pain management medicines - The new enterprise will be branded as Grünenthal Meds. Grünenthal owns a 51 percent majority share and ...
mehrPress release : STADA further grows its European Consumer Healthcare portfolio by acquiring several additional brands from Sanofi
Ein Dokumentmehr- 3
Battery power in every situation: SEVERIN is new Power X-Change platform partner of Einhell
mehr NOMOS Glashütte/SA Roland Schwertner KG
8The Little Gold Watch: Ludwig Gold 33, the New Ladies’ Watch from NOMOS Glashütte
mehrBrenntag’s Pharma section signs exclusive agreement for health-promoting product line Akovita ELIP in EMEA
Ein DokumentmehrLingoda Partners with Fēst Virtual Cooking to Offer Free Language and Cooking Classes for the Holidays / 2 in 1: Become a Master Chef and Improve your Language Skills
mehrCPhI worldwide: German probiotics company SYNformulas seeks partnerships to drive internationalization
mehrCPhI worldwide: German probiotics company SYNformulas seeks partnerships to drive internationalization
Press release Combating intestinal complaints and allergies CPhI worldwide: German probiotics company SYNformulas seeks partnerships to drive internationalization - SYNformulas, leading probiotics supplier from Germany, will exhibit for the first time at the pharmaceutical trade fair CPhI worldwide in Milan - Focus ...
mehrLebrikizumab significantly improved skin clearance and itch in people with moderate-to-severe atopic deramatitis in two Phase 3 trials
Barcelona (ots/PRNewswire) - - Primary and all key secondary endpoints including itch, interference of itch on sleep and quality of life were met at Week 16 in two pivotal Phase 3 trials - Safety profile consistent with prior lebrikizumab studies in atopic dermatitis Lebrikizumab led to significant improvements with ...
mehrGastrulation research reveals novel details about embryonic development
mehr- 2
Plant Protector: How plants strengthen their light-harvesting membranes against environmental stress
mehr Technische Universität München
Effects of climate change on nature visualized - Interview with Professor Annette Menzel on the idea of Green Warming Stripes
Corporate Communications Center phone: +49 8161 5403 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/36528/ Interview with Professor Annette Menzel on the idea of Green Warming Stripes Effects of climate change on nature visualized To ...
mehrFirst pocket inhaler for Covid-19 and other viral mutations
Buochs (ots) - DG-Nika AG – a new approach to therapy & proactive protection from the pandemic The corona pandemic continues to pose a global threat: To date, it has been possible to vaccinate only a small fraction of the total population. On top of that, there is acute danger from mutations of this virus. Against this backdrop, the DG-Nika AG research team has developed a solution for a new approach to protecting the ...
mehr- 5
Commemorative publication for the 25th anniversary of the IZB presents 70 profiles and visions of successful biotech start-ups
Ein Dokumentmehr Follow your gut: How farms protect from childhood asthma
mehrNasal biomarkers predict severity of pollen-specific allergy symptoms
Nasal biomarkers predict severity of pollen-specific allergy symptoms It is not only people with allergies, but also a subgroup of people without one that suffer in spring and have nasal problems from contact with pollen. A new study shows that biomarkers in the nose can predict ...
mehr
12Nächste